Blood Test Shows High Sensitivity for Early-Stage Lung Cancer Detection
Initial results from a real-world study of the ProVue Lung test demonstrate 83% sensitivity for Stage I cancer in high-risk patients.
Read More
Search Results for: lung cancer
Blood Test Boosts Lung Cancer Screening Participation
New clinical utility data showed that offering a blood-based lung cancer test increased screening participation compared with low-dose CT screening alone.
Read More
FDA Approves Tissue-Based Companion Diagnostic for PIK3CA-Mutated Breast Cancer
The diagnostic test identifies specific genetic mutations to help select patients for a targeted therapy combination.
Read More
Personalis Data Highlights Early Cancer Recurrence Detection
Clinical results show high sensitivity for colorectal cancer relapse and ultra-low detection limits for lung cancer.
Read More
FDA Approves New Companion Diagnostics for Prostate Cancer Treatment
The tissue- and blood-based tests identify patients with specific gene mutations who may benefit from a combination therapy.
Read More